The National Institute on Drug Abuse (NIDA) is offering this grant to support fundamental research focused on understanding the complex interplay between addictive drugs and HIV infection. This initiative aims to delineate signaling pathways and mechanisms, including critical HIV-host protein interactions and post-translational modifications, through which these factors converge to induce changes in brain function. This grant is for the purpose of elucidating neuropathological alterations and neurocognitive dysfunctions resulting from this intersection. Furthermore, a key objective is to promote the discovery and development of novel chemical and biological approaches. These innovative strategies are vital for the prevention or mitigation of central nervous system complications frequently associated with both HIV infection and various substance use disorders.
Opportunity ID: 344954
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-24-013 |
| Funding Opportunity Title: | Mechanisms and Targets at the Intersection of HIV and Substance Use (R01 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 16, 2022 |
| Last Updated Date: | Dec 16, 2022 |
| Original Closing Date for Applications: | Aug 09, 2023 |
| Current Closing Date for Applications: | Aug 09, 2023 |
| Archive Date: | Sep 14, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public housing authorities/Indian housing authorities Special district governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts City or township governments Public and State controlled institutions of higher education Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this FOA is to support basic research on signaling pathways and mechanisms including HIV-host protein interactions and post-translational modifications by which addictive drugs and HIV infection converge to induce changes in brain function and cause neuropathological alterations and neurocognitive dysfunctions. This FOA also aims to promote discovery and development of novel chemical and biological approaches for prevention or mitigation of CNS complications associated with HIV infection and substance use disorders. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 344954 Full Announcement-RFA-DA-24-013 -> RFA-DA-24-013-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278949 | Jul 09, 2023 | Aug 09, 2023 | View |
Package 1
Mandatory forms
344954 RR_SF424_5_0-5.0.pdf
344954 PHS398_CoverPageSupplement_5_0-5.0.pdf
344954 RR_OtherProjectInfo_1_4-1.4.pdf
344954 PerformanceSite_4_0-4.0.pdf
344954 RR_KeyPersonExpanded_4_0-4.0.pdf
344954 PHS398_ResearchPlan_5_0-5.0.pdf
344954 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344954 RR_Budget_3_0-3.0.pdf
344954 RR_SubawardBudget30_3_0-3.0.pdf
344954 PHS398_ModularBudget_1_2-1.2.pdf
344954 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
